Exchange: NASDAQ·Updated 09:51 AM EDT
News
all
press releases
Quanterix (QTRX) Q2 2026 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
More News
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers iTonic Holdings (NASDAQ:ITOC) stock moved upwards by 32.0% to $0.41 during Friday's after-market session. The company's market cap stands at $4.9 million. Quanterix (NASDAQ:QTRX) shares increased byread more...
Benzinga
Quanterix Q2 Earnings Call Highlights
Quanterix Q2 Earnings Call Highlights...
Yahoo! Finance: News
Quanterix Names Jim Gute Chief Commercial Officer
Quanterix Corporation (Nasdaq: QTRX), a global leader in precision biomarker science, today announced that seasoned healthcare executive Jim Gute has been appointed Chief Commercial Officer of the company. In this role, he will lead a re-acceleration of growth within the companys commercial...
Business Wire
Quanterix Releases Financial Results for the Second Quarter of 2026
Quanterix Corporation (NASDAQ: QTRX), a global leader in precision biomarker science, today announced financial results for the second quarter ended June 30, 2026. We made meaningful progress in the second quarter, including strengthening our leadership team and preserving cash better than planned...
Business Wire
Quanterix To Participate in Canaccord Genuity Capital Markets 46th Annual Growth Conference on August 11-12
Quanterix Corporation (Nasdaq: QTRX), a global leader in precision biomarker science, today announced that senior management will participate in the Canaccord Genuity Capital Markets 46th Annual Growth Conference at the Intercontinental Hotel in Boston on August 11-12, 2026. Chief Executive Officer...
Business Wire
Quanterix To Report Second Quarter 2026 Financial Results on August 10, 2026
Quanterix Corporation (Nasdaq: QTRX), a global leader in precision biomarker science, today announced that it will host a conference call on Monday, August 10, 2026, at 8:30 AM ET, to discuss its second quarter 2026 financial results. Quanterix will issue a press release regarding its second...
Business Wire
Quanterix Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Quanterix Corporation (Quanterix or the Company) (NASDAQ: QTRX), a global leader in precision biomarker science, today announced that on July 15, 2026, an inducement grant (the Inducement Grant) was made to Jason Faessler in connection with the commencement of his employment as the Chief Financial...
Business Wire
Anthem Blue Cross and Blue Shield Establishes Commercial Coverage for LucentAD Complete; Quanterix to Present New Data Highlighting Multi-Analyte Advantages
Quanterix Corporation (NASDAQ: QTRX), a global leader in precision biomarker science, today announced a series of milestones that significantly advance the clinical adoption of blood-based Alzheimers testing. Together, these milestones reinforce the growing role of LucentAD Complete, Quanterixs...
Business Wire
Tuesday Sector Laggards: Medical Instruments & Supplies, Cigarettes & Tobacco Stocks
In trading on Tuesday, medical instruments & supplies shares were relative laggards, down on the day by about 2.5%. Helping drag down the group were shares of Enovis, off about 11.2% and shares of Quanterix off about 9% on the day. Also lagging the market Tuesday are cigar...
Nasdaq News: Markets

Advertisement|Remove ads.